Nanjing Vazyme Biotech Co Ltd (688105) — Cash Flow Reinvestment Rate
Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥15.83 Million (capex CN¥15.83 Million ) from operating cash flow of CN¥75.30 Million. Explore 688105 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Also explore Nanjing Vazyme Biotech Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nanjing Vazyme Biotech Co Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Nanjing Vazyme Biotech Co Ltd. For live market cap and broader valuation context, see 688105 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.39x | CN¥323.20 Million | CN¥233.16 Million | CN¥47.39 Million | ▼ -75.7% |
| 2023 | 5.71x | CN¥1.13 Billion | CN¥198.40 Million | CN¥232.90 Million | ▲ +119.3% |
| 2022 | 2.61x | CN¥1.92 Billion | CN¥735.17 Million | CN¥962.86 Million | ▼ -4.9% |
| 2021 | 2.74x | CN¥1.69 Billion | CN¥616.80 Million | CN¥261.96 Million | ▲ +102.8% |
| 2020 | 1.35x | CN¥1.09 Billion | CN¥803.55 Million | CN¥152.54 Million | ▼ -36.0% |
| 2019 | 2.11x | CN¥32.08 Million | CN¥15.20 Million | CN¥19.88 Million | — |